PRIMADIAG Revenue and Competitors

Romainville,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • PRIMADIAG's estimated annual revenue is currently $2.6M per year.(i)
  • PRIMADIAG's estimated revenue per employee is $155,000

Employee Data

  • PRIMADIAG has 17 Employees.(i)
  • PRIMADIAG grew their employee count by -29% last year.

PRIMADIAG's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is PRIMADIAG?

PrimaDiag, a French company, based at Biocitech (dedicated to Science and biotechnologies) park in the Paris area, develops compact robotics platforms for rapid automation of a large variety of biology protocols and in particular for molecular biology protocols. PrimaDiag began as an engineering consulting firm in October, 2007 and acquired expertise in the domains of robotics, computer science and biology through various projects realized in France and in Europe. In 2014, with its acquired experience, PrimaDiag launched its new range of ” ACSIA “ products offering turnkey solutions, based on a new concept, for the better part of biological protocols. The concept has a set of bases and a set of robotics accessories which can be combined to support a given protocol and managed by a very powerful and user friendly software, PrimaController®II. Reliable and robust, the ACSIA product line is ideal to prepare of PCR / qPCR, plates, he purification of nucleic acids, the preparation of libraries and the NGS protocol captures as well as any other protocol requiring the handling of liquids. The ACSIA product line is designed and manufactured in France with the best value for money to perform a wide variety of liquid handling protocols with least end user effort and a mastered cost for a rapid return on investment.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$2.6M

Revenue (est)

-29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PRIMADIAG News

2022-04-17 - Préouverture Paris : le CAC40 toujours bien disposé

Biosynex a pris 23,31% du capital de Primadiag. Alstom : contrat de 700 ME pour 100 tramways à Melbourne. ©2022 Boursier.com.

2022-04-13 - Biosynex : prise de participation de 23.31% dans Primadiag

Primadiag a notamment développé une plateforme robotique modulaire qui permet d'automatiser la préparation des analyses biologiques et...

2022-04-13 - Les valeurs à suivre demain à la Bourse de Paris Jeudi 21 avril 2022

Primadiag a développé une plateforme robotique modulaire qui permet d'automatiser la préparation des analyses biologiques et génétiques.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M2812%N/A
#2
$4.8M317%N/A
#3
$3.4M42-19%N/A